TY - JOUR
T1 - Elucidation of the Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons
AU - Urban, Daniel J.
AU - Zhu, Hu
AU - Marcinkiewcz, Catherine A.
AU - Michaelides, Michael
AU - Oshibuchi, Hidehiro
AU - Rhea, Darren
AU - Aryal, Dipendra K.
AU - Farrell, Martilias S.
AU - Lowery-Gionta, Emily
AU - Olsen, Reid H.J.
AU - Wetsel, William C.
AU - Kash, Thomas L.
AU - Hurd, Yasmin L.
AU - Tecott, Laurence H.
AU - Roth, Bryan L.
N1 - Publisher Copyright:
© 2016 American College of Neuropsychopharmacology. All rights reserved.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Elucidating how the brain's serotonergic network mediates diverse behavioral actions over both relatively short (minutes-hours) and long period of time (days-weeks) remains a major challenge for neuroscience. Our relative ignorance is largely due to the lack of technologies with robustness, reversibility, and spatio-temporal control. Recently, we have demonstrated that our chemogenetic approach (eg, Designer Receptors Exclusively Activated by Designer Drugs (DREADDs)) provides a reliable and robust tool for controlling genetically defined neural populations. Here we show how short- and long-term activation of dorsal raphe nucleus (DRN) serotonergic neurons induces robust behavioral responses. We found that both short- and long-term activation of DRN serotonergic neurons induce antidepressant-like behavioral responses. However, only short-term activation induces anxiogenic-like behaviors. In parallel, these behavioral phenotypes were associated with a metabolic map of whole brain network activity via a recently developed non-invasive imaging technology DREAMM (DREADD Associated Metabolic Mapping). Our findings reveal a previously unappreciated brain network elicited by selective activation of DRN serotonin neurons and illuminate potential therapeutic and adverse effects of drugs targeting DRN neurons.
AB - Elucidating how the brain's serotonergic network mediates diverse behavioral actions over both relatively short (minutes-hours) and long period of time (days-weeks) remains a major challenge for neuroscience. Our relative ignorance is largely due to the lack of technologies with robustness, reversibility, and spatio-temporal control. Recently, we have demonstrated that our chemogenetic approach (eg, Designer Receptors Exclusively Activated by Designer Drugs (DREADDs)) provides a reliable and robust tool for controlling genetically defined neural populations. Here we show how short- and long-term activation of dorsal raphe nucleus (DRN) serotonergic neurons induces robust behavioral responses. We found that both short- and long-term activation of DRN serotonergic neurons induce antidepressant-like behavioral responses. However, only short-term activation induces anxiogenic-like behaviors. In parallel, these behavioral phenotypes were associated with a metabolic map of whole brain network activity via a recently developed non-invasive imaging technology DREAMM (DREADD Associated Metabolic Mapping). Our findings reveal a previously unappreciated brain network elicited by selective activation of DRN serotonin neurons and illuminate potential therapeutic and adverse effects of drugs targeting DRN neurons.
UR - http://www.scopus.com/inward/record.url?scp=84960863666&partnerID=8YFLogxK
U2 - 10.1038/npp.2015.293
DO - 10.1038/npp.2015.293
M3 - Article
C2 - 26383016
AN - SCOPUS:84960863666
SN - 0893-133X
VL - 41
SP - 1404
EP - 1415
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 5
ER -